The final steps of erythropoiesis involve unique cellular processes including enucleation
and reorganization of membrane proteins and the cytoskeleton to produce biconcave …

Background Chronic red blood cell transfusion is the first-line treatment for severe forms of
thalassaemia. This therapy is, however, hampered by a number of adverse effects, including …

Objectives Most literature on the frequencies of red blood cell (RBC) phenotypes are
published in Europeans and Africans countries, with the frequencies in the Omani …

Background. Transfusion of red blood cells (RBC) is an essential therapeutic tool in sickle
cell disease (SCD). Repeated RBC transfusions can cause alloimmunization which causes …

Objectives The present study aimed to gain more insight into, and summarise, blood
donation determinants among migrants or minorities of Sub‐Saharan heritage by …

Purpose Sickle cell disease (SCD) and thalassemia are common inherited blood disorders
in Saudi Arabia, especially in Jazan Province. Patients with these disorders require multiple …

Introduction. The risk of developing transfusion‐related complications, especially
alloimmunization, is an ongoing concern for transfusion‐dependent patients. It is important …

BACKGROUND Blood transfusion is the first‐line treatment for patients with thalassemia and
many sickle cell patients. However, cases of unregulated blood transfusion are shown to …

The treatment of sickle cell disease (SCD) is mainly supportive, except for a minority, who
receive bone marrow transplantation (BMT). Serum ferritin (SF) is routinely available but is …

Introduction The alloimmunization following blood transfusion can be life‐threatening. The
Rh alloantibodies are one of the most common causes contributing to alloimmunization. This …